Pharmacometrics of high-dose ivermectin in early COVID-19 from an open label, randomized, controlled adaptive platform trial (PLATCOV).
William H K SchillingPodjanee JittamalaJames A WatsonManeerat EkkapongpisitTanaya SiripoonThundon NgamprasertchaiViravarn LuviraSasithorn PongwilaiCintia Valeria CruzJames John CallerySimon BoydVaraporn KruabkonthoThatsanun NgernsengJaruwan TubprasertMohammad Yazid AbdadNattaporn PiaraksaKanokon SuwannasinPongtorn HanboonkunupakarnBorimas HanboonkunupakarnSakol SookpromeKittiyod PoovorawanJanjira ThaipadungpanitStuart BlacksellMallika ImwongJoel TarningWalter R J TaylorVasin ChotivanichChunlanee SangketchonWiroj RuksakulKesinee ChotivanichMauro Martins TexeiraSasithon PukrittayakameeArjen M DondorpNicholas Philip John DayWatcharapong PiyaphaneeWeerapong PhumratanaprapinNicholas J Whitenull nullPublished in: eLife (2023)
NCT05041907.